<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To determine the 1H <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> spectroscopic (MRS) findings and intergroup differences among common <z:hpo ids='HP_0000726'>dementias</z:hpo>: <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> (AD), vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD), <z:hpo ids='HP_0000726'>dementia</z:hpo> with <z:hpo ids='HP_0100315'>Lewy bodies</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLB</z:e>), and <z:e sem="disease" ids="C0751072" disease_type="Mental or Behavioral Dysfunction" abbrv="FTLD">frontotemporal lobar degeneration</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The authors consecutively recruited 206 <z:mpath ids='MPATH_458'>normal</z:mpath> elderly subjects and 121 patients with AD, 41 with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e>, 20 with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLB</z:e>, and 8 with VaD </plain></SENT>
<SENT sid="2" pm="."><plain>The 1H MRS metabolite ratio changes in common <z:hpo ids='HP_0000726'>dementias</z:hpo> were evaluated with respect to <z:mpath ids='MPATH_458'>normal</z:mpath> and also differences among the common <z:hpo ids='HP_0000726'>dementias</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: N-acetylaspartate (<z:chebi fb="8" ids="32918">NAA</z:chebi>)/<z:chebi fb="2" ids="16919">creatine</z:chebi> (Cr) was lower than <z:mpath ids='MPATH_458'>normal</z:mpath> in patients with AD, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e>, and VaD </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="17268">Myo-inositol</z:chebi> (mI)/Cr was higher than <z:mpath ids='MPATH_458'>normal</z:mpath> in patients with AD and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="3" ids="15354">Choline</z:chebi> (Cho)/Cr was higher than <z:mpath ids='MPATH_458'>normal</z:mpath> in patients with AD, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e>, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLB</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>There were no metabolite differences between patients with AD and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e> or between patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLB</z:e> and VaD </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="8" ids="32918">NAA</z:chebi>/Cr was lower in patients with AD and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e> than <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLB</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>MI/Cr was higher in patients with AD and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e> than VaD </plain></SENT>
<SENT sid="9" pm="."><plain>MI/Cr was also higher in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e> than <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLB</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: <z:chebi fb="8" ids="32918">NAA</z:chebi>/Cr levels are decreased in <z:hpo ids='HP_0000726'>dementias</z:hpo> that are characterized by neuron loss, such as AD, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e>, and VaD </plain></SENT>
<SENT sid="11" pm="."><plain>MI/Cr levels are elevated in <z:hpo ids='HP_0000726'>dementias</z:hpo> that are pathologically characterized by <z:hpo ids='HP_0002171'>gliosis</z:hpo>, such as AD and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Cho/Cr levels are elevated in <z:hpo ids='HP_0000726'>dementias</z:hpo> that are characterized by a profound cholinergic deficit, such as AD and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLB</z:e> </plain></SENT>
</text></document>